Lupin Limited Launches Generic Wellbutrin XL Tablets in the US
DSIJ Intelligence / 15 Jun 2017
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, active pharmaceutical ingredients (APIs) and biotechnology products across the world.
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, active pharmaceutical ingredients (APIs) and biotechnology products across the world.It is the seventh-largest company by market capitalization; the 10th-largest generic pharmaceutical company by revenue globally and has launched the generic Wellbutrin XL tablets in the US.
As per IMS data, Wellbutrin XL is used to treat major depressive disorder in adults and has US sales of $758 million till May 2017.
At Rs 1184 per share, the stock on the NSE was trading higher by Rs 3 per share or 0.3%. The stock has delivered negative returns of 19% in a period of one year and has under performed the BSE Sensex and BSE Healthcare indices over the same time span.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.